Does anyone survive pancreatic ductal adenocarcinoma? A nationwide study re-evaluating the data of the Finnish Cancer Registry, Gut, vol.54, issue.3, pp.385-392, 2005. ,
Cancer of the Pancreas: Are we Making Progress? A Review of Studies in the US Oncology Research Network, Cancer Control, vol.25, issue.18, pp.308-321, 2008. ,
DOI : 10.1200/JCO.2005.01.9661
Cancer statistics, 2015. CA Cancer J Clin, pp.5-29, 2015. ,
Available from: https://www.pancan.org/wp-content/uploads FOLFIRINOX Induction Therapy for Stage 3 Pancreatic Adenocarcinoma, Pancreatic Cancer Action Network. Pancreatic Cancer Facts 2016, pp.3512-3533, 2015. ,
Preoperative/Neoadjuvant Therapy in Pancreatic Cancer: A Systematic Review and Meta-analysis of Response and Resection Percentages, PLoS Medicine, vol.23, issue.4, p.1000267, 2010. ,
DOI : 10.1371/journal.pmed.1000267.s005
Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012, European Journal of Cancer, vol.49, issue.6, pp.1374-403, 2013. ,
DOI : 10.1016/j.ejca.2012.12.027
The Epidemiology of Pancreatitis and Pancreatic Cancer, Gastroenterology, vol.144, issue.6, pp.1252-61, 2013. ,
DOI : 10.1053/j.gastro.2013.01.068
Tobacco and the risk of pancreatic cancer: a review and meta-analysis. Langenbecks Arch Surg, pp.535-580, 2008. ,
Body Mass Index and Risk, Age of Onset, and Survival in Patients With Pancreatic Cancer, JAMA, vol.301, issue.24, pp.2553-62, 2009. ,
DOI : 10.1001/jama.2009.886
Cancer et diabète de type II [Internet] Available from, 2017. ,
Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies, British Journal of Cancer, vol.95, issue.11, pp.2076-83, 2005. ,
DOI : 10.1093/jnci/djg105
An update on familial pancreatic cancer and the management of asymptomatic relatives, HPB, vol.9, issue.1, pp.4-7, 2007. ,
DOI : 10.1080/13651820600985325
Pancreatic cancer in chronic pancreatitis; aetiology, incidence, and early detection, Best Practice & Research Clinical Gastroenterology, vol.24, issue.3, pp.349-58, 2010. ,
DOI : 10.1016/j.bpg.2010.02.007
Probability of Pancreatic Cancer Following Diabetes: A Population-Based Study, Gastroenterology, 2005. ,
Imagerie de l'adénocarcinome du pancréas. Datarevues0221036300866-C2759 [Internet], 2008. ,
Pancreatic neoplasms: how useful is evaluation with US? Radiology, pp.341-345, 1988. ,
Thin-section contrast-enhanced computed tomography accurately predicts the resectability of malignant pancreatic neoplasms, The American Journal of Surgery, vol.167, issue.1, pp.104-115, 1994. ,
DOI : 10.1016/0002-9610(94)90060-4
The Role of High-Resolution Multislice Spiral CT in the Diagnosis and Assessment of Resectability Available from: https, Internet]. PubMed Journals, 12541123. ,
Pancreatic-phase versus portal vein-phase helical CT of the pancreas: optimal temporal window for evaluation of pancreatic adenocarcinoma., American Journal of Roentgenology, vol.172, issue.3, pp.605-613, 1999. ,
DOI : 10.2214/ajr.172.3.10063844
Multi???Detector Row Helical CT of the Pancreas: Effect of Contrast-enhanced Multiphasic Imaging on Enhancement of the Pancreas, Peripancreatic Vasculature, and Pancreatic Adenocarcinoma, Radiology, vol.220, issue.1, 2001. ,
DOI : 10.1148/radiology.220.1.r01jl1897
Arterial versus portal venous helical CT for revealing pancreatic adenocarcinoma: conspicuity of tumor and critical vascular anatomy., American Journal of Roentgenology, vol.169, issue.1 ,
DOI : 10.2214/ajr.169.1.9207510
Pancreatic Malignancy: Value of Arterial, Pancreatic, and Hepatic Phase Imaging with Multi???Detector Row CT, Radiology, vol.229, issue.1, pp.81-90, 2003. ,
DOI : 10.1148/radiol.2291020582
Two-phase helical CT for pancreatic tumors: pancreatic versus hepatic phase enhancement of tumor, pancreas, and vascular structures., Radiology, vol.199, issue.3, pp.697-701, 1996. ,
DOI : 10.1148/radiology.199.3.8637990
Pancreatic tumors: comparison of dual-phase helical CT and endoscopic sonography., American Journal of Roentgenology, vol.170, issue.5, 1998. ,
DOI : 10.2214/ajr.170.5.9574609
Potentially resectable pancreatic adenocarcinoma: spiral CT assessment with surgical and pathologic correlation., Radiology, vol.197, issue.2, pp.381-386, 1995. ,
DOI : 10.1148/radiology.197.2.7480681
Adenocarcinoma of the pancreatic ducts: comparative evaluation with CT and MR imaging at 1.5 T., Radiology, vol.183, issue.1, 1992. ,
DOI : 10.1148/radiology.183.1.1312736
The Role of PET Scanning in Pancreatic Cancer, Advances in Surgery, vol.44, issue.1, pp.313-338, 2010. ,
DOI : 10.1016/j.yasu.2010.05.007
Imaging preoperatively for pancreatic adenocarcinoma, J Gastrointest Oncol Mar, vol.276, issue.4, pp.343-57, 2015. ,
Influence of Resection Margins on Survival for Patients With Pancreatic Cancer Treated by Adjuvant Chemoradiation and/or Chemotherapy in the ESPAC-1 Randomized Controlled Trial, Annals of Surgery, vol.234, issue.6, pp.758-68, 2001. ,
DOI : 10.1097/00000658-200112000-00007
Effect of Hospital Volume on Margin Status after Pancreaticoduodenectomy for Cancer, Journal of the American College of Surgeons, vol.207, issue.4, pp.510-519, 2008. ,
DOI : 10.1016/j.jamcollsurg.2008.04.033
Definition of a standard lymphadenectomy in surgery for pancreatic ductal adenocarcinoma: A consensus statement by the International Study Group on Pancreatic Surgery (ISGPS), Surgery, vol.156, issue.3, pp.591-600, 2014. ,
DOI : 10.1016/j.surg.2014.06.016
Cancer du pancréas [Internet]. 112AD, 2017. ,
Dataset for the histopathological reporting of carcinomas of the pancreas, ampulla of vater and common bile duct. Royal College of Pathologist, 2017. ,
Margin Clearance and Outcome in Resected Pancreatic Cancer, Journal of Clinical Oncology, vol.27, issue.17, pp.2855-62, 2009. ,
DOI : 10.1200/JCO.2008.20.5104
Pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: a French multicentre prospective evaluation of resection margins in 150 evaluable specimens, HPB, vol.16, issue.1, 2014. ,
DOI : 10.1111/hpb.12061
Definition of Microscopic Tumor Clearance (R0) in Pancreatic Cancer Resections, Cancers, vol.238, issue.4, pp.2001-2011, 2010. ,
DOI : 10.1016/j.gassur.2006.08.018
Impact of FOLFIRINOX Compared With Gemcitabine on Quality of Life in Patients With Metastatic Pancreatic Cancer: Results From the PRODIGE 4/ACCORD 11 Randomized Trial, Journal of Clinical Oncology, vol.31, issue.1, pp.23-32, 2013. ,
DOI : 10.1200/JCO.2012.44.4869
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer, New England Journal of Medicine, vol.364, issue.19, pp.1817-1842, 2011. ,
DOI : 10.1056/NEJMoa1011923
URL : https://hal.archives-ouvertes.fr/hal-00598658
Meta-analysis of randomised adjuvant therapy trials for pancreatic cancer, British Journal of Cancer, vol.341, issue.8, pp.1372-81, 2005. ,
DOI : 10.1002/cncr.10831
A Randomized Trial of Chemoradiotherapy and Chemotherapy after Resection of Pancreatic Cancer, New England Journal of Medicine, vol.350, issue.12, pp.1200-1210, 2004. ,
DOI : 10.1056/NEJMoa032295
Adjuvant Chemotherapy With Gemcitabine and Long-term Outcomes Among Patients With Resected Pancreatic Cancer, JAMA, vol.310, issue.14, pp.1473-81, 2009. ,
DOI : 10.1001/jama.2013.279201
Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid vs Gemcitabine Following Pancreatic Cancer Resection, JAMA, vol.304, issue.10, pp.1073-81, 2010. ,
DOI : 10.1001/jama.2010.1275
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine, New England Journal of Medicine, vol.369, issue.18, pp.1691-703, 2013. ,
DOI : 10.1056/NEJMoa1304369
Development of nanoliposomal irinotecan (nal-IRI, MM-398, PEP02) in the management of metastatic pancreatic cancer, Expert Opinion on Pharmacotherapy, vol.33, issue.10, pp.1413-1433 ,
DOI : 10.1016/S0140-6736(15)01035-1
Erlotinib in the treatment of advanced pancreatic cancer, Biol Targets Ther, vol.2, issue.1, pp.83-95, 2008. ,
Genomic analyses identify molecular subtypes of pancreatic cancer, Nature, vol.4, issue.7592, pp.47-52, 2016. ,
DOI : 10.1038/ncomms3612
Surgical Resection after Radiochemotherapy in Patients with Unresectable Adenocarcinoma of the Pancreas, Journal of the American College of Surgeons, vol.201, issue.3, pp.359-65, 2005. ,
DOI : 10.1016/j.jamcollsurg.2005.04.008
Subsequent resection of locally advanced pancreatic carcinoma after chemoradiotherapy, Gastroent??rologie Clinique et Biologique, vol.30, issue.2, 2006. ,
DOI : 10.1016/S0399-8320(06)73157-8
Pancreaticoduodenectomy following chemoradiotherapy for locally advanced adenocarcinoma of the pancreatic head, HPB, vol.15, issue.9, pp.716-739, 2013. ,
DOI : 10.1111/hpb.12039
Neoadjuvant FOLFIRINOX for Borderline Resectable Pancreas Cancer: A New Treatment Paradigm?, The Oncologist, vol.19, issue.3, pp.266-74, 2014. ,
DOI : 10.1634/theoncologist.2013-0273
Pancreatic head resectable adenocarcinoma: preoperative chemoradiation improves local control but does not affect survival, HPB, vol.13, issue.1, pp.64-73, 2011. ,
DOI : 10.1111/j.1477-2574.2010.00245.x
Neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of prospective studies, Cancer Medicine, vol.20, issue.Suppl 3, 2017. ,
DOI : 10.3748/wjg.v20.i31.10740
Definitive concurrent chemoradiotherapy in locally advanced pancreatic cancer, Radiation Oncology Journal, vol.32, issue.2, pp.49-56 ,
DOI : 10.3857/roj.2014.32.2.49
Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib, JAMA, vol.315, issue.17, pp.1844-53, 2016. ,
DOI : 10.1001/jama.2016.4324
Neoadjuvant Therapy for Pancreatic Cancer, American Journal of Clinical Oncology, vol.39, issue.3, pp.302-315 ,
DOI : 10.1097/COC.0000000000000278
Int??r??t de la chimio-radioth??rapie n??o-adjuvante dans le cancer pancr??atique, Gastroent??rologie Clinique et Biologique, vol.30, issue.12, 1375. ,
DOI : 10.1016/S0399-8320(06)73558-8
Preoperative chemotherapy of chemoradiotherapy for the treatment of adenocarcinoma of the pancreas and ampulla of Vater, Journal of Hepato-Biliary-Pancreatic Surgery, vol.5, issue.3, pp.251-255, 1998. ,
DOI : 10.1007/s005340050042
Radiothérapie des cancers du pancréas. Cancer/Radiothérapie, pp.169-73, 2016. ,
Radiotherapy Technical Considerations in the Management of Locally Advanced Pancreatic Cancer: American-French Consensus Recommendations, International Journal of Radiation Oncology*Biology*Physics, vol.83, issue.5, pp.1355-64, 2012. ,
DOI : 10.1016/j.ijrobp.2011.11.050
Gemcitabine with a specific conformal 3D 5FU radiochemotherapy technique is safe and effective in the definitive management of locally advanced pancreatic cancer, British Journal of Cancer, vol.6, issue.4, pp.464-71, 2007. ,
DOI : 10.1200/JCO.2005.23.911
Full-Dose Gemcitabine and Concurrent Radiotherapy for Unresectable Pancreatic Cancer, International Journal of Radiation Oncology*Biology*Physics, vol.68, issue.3, pp.801-809, 2007. ,
DOI : 10.1016/j.ijrobp.2006.12.053
Therapy of locally unresectable pancreatic carcinoma: A randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil. The gastrointestinal tumor study group, Cancer, vol.47, issue.8, pp.1705-1715, 1981. ,
DOI : 10.1002/1097-0142(19811015)48:8<1705::AID-CNCR2820480803>3.0.CO;2-4
Chemoradiotherapy in the Management of Locally Advanced Pancreatic Carcinoma: A Qualitative Systematic Review, Journal of Clinical Oncology, vol.27, issue.13, pp.2269-77, 2009. ,
DOI : 10.1200/JCO.2008.19.7921
Intensity-modulated radiotherapy in treatment of pancreatic and bile duct malignancies: toxicity and clinical outcome, International Journal of Radiation Oncology*Biology*Physics, vol.59, issue.2, pp.445-53, 2004. ,
DOI : 10.1016/j.ijrobp.2003.11.003
Intensity modulated radiation therapy employing the volume at risk approach to minimize small bowel and renal toxicity when treating patients with locally advanced pancreatic carcinomas, International Journal of Radiation Oncology*Biology*Physics, vol.51, issue.3, p.270, 2001. ,
DOI : 10.1016/S0360-3016(01)02319-7
Gemcitabine-based or capecitabine-based chemoradiotherapy for locally advanced pancreatic cancer (SCALOP): a multicentre, randomised, phase 2 trial, The Lancet Oncology, vol.14, issue.4, pp.317-343 ,
DOI : 10.1016/S1470-2045(13)70021-4
Locally Advanced Pancreatic Cancer: The Role of Definitive Chemoradiotherapy, Clinical Oncology, vol.26, issue.9, pp.560-568, 2014. ,
DOI : 10.1016/j.clon.2014.06.002
Quantifying tumour heterogenity with CT, Cancer Imaging, 2013. ,
Assessment of tumor heterogeneity: an emerging imaging tool for clinical practice? Insights Imaging, 2012. ,
Early prediction of tumor recurrence based on CT texture changes after stereotactic ablative radiotherapy (SABR) for lung cancer, Medical Physics, vol.132, issue.suppl 6, 2014. ,
DOI : 10.1378/chest.06-2325
CT Textural Analysis (CTTA) of Metastatic Treatment Resistant Pancreatic Adenocarcinoma (PDAC): Identifying Biomarkers for Genetic Instability and Overall Survival [Internet]. University of Arizona, 2016. ,
FOLFIRINOX for Locally Advanced Pancreatic Adenocarcinoma: Results of an AGEO Multicenter Prospective Observational Cohort, Annals of Surgical Oncology, vol.17, issue.11, pp.295-301 ,
DOI : 10.1245/s10434-010-1285-8
FOLFIRINOX-Based Neoadjuvant Therapy in Borderline Resectable or Unresectable Pancreatic Cancer, Pancreas, vol.44, issue.4, pp.515-536, 2015. ,
DOI : 10.1097/MPA.0000000000000314
FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis, The Lancet Oncology, vol.17, issue.6, pp.801-811 ,
DOI : 10.1016/S1470-2045(16)00172-8
Borderline resectable pancreatic cancer: Definitions and management, World Journal of Gastroenterology, vol.20, issue.31, pp.10740-51, 2014. ,
DOI : 10.1371/journal.pmed.1000267
Management of borderline resectable pancreatic cancer, World J Gastrointest Oncol, vol.7, issue.10, pp.241-250, 2015. ,
An evaluation of the accuracy of CT when determining resectability of pancreatic head adenocarcinoma after neoadjuvant treatment, European Journal of Radiology, vol.82, issue.4, pp.589-93 ,
DOI : 10.1016/j.ejrad.2012.12.002
Early Recurrence of Pancreatic Cancer after Resection and During Adjuvant Chemotherapy, Saudi J Gastroenterol Off J Saudi Gastroenterol Assoc, vol.18, issue.2, pp.118-139, 2012. ,
Patterns of recurrence after curative resection of pancreatic ductal adenocarcinoma, European Journal of Surgical Oncology (EJSO), vol.35, issue.6, pp.600-604, 2009. ,
DOI : 10.1016/j.ejso.2008.12.006
Chemoradiation in patients with isolated recurrent pancreatic cancer - therapeutical efficacy and probability of re-resection, Radiation Oncology, vol.8, issue.1, p.27, 2013. ,
DOI : 10.1186/1748-717X-8-27
Patterns of Recurrence After Curative Resection of Pancreatic Cancer, Based on Autopsy Findings, Journal of Gastrointestinal Surgery, vol.10, issue.4, pp.511-519, 2006. ,
DOI : 10.1016/j.gassur.2005.09.016
Pancreatic Adenocarcinoma with Venous Involvement: Is Up-Front Synchronous Portal-Superior Mesenteric Vein Resection Still Justified? A Survey of the Association Fran??aise de Chirurgie, Annals of Surgical Oncology, vol.19, issue.suppl 3, pp.1874-83, 2015. ,
DOI : 10.1245/s10434-011-2110-8
Pretreatment Assessment of Resectable and Borderline Resectable Pancreatic Cancer: Expert Consensus Statement by Callery et al., Annals of Surgical Oncology, vol.16, issue.7, 2009. ,
DOI : 10.1245/s10434-009-0411-y
Stereotactic Body Radiation Therapy for Locally Advanced and Borderline Resectable Pancreatic Cancer Is Effective and Well Tolerated, International Journal of Radiation Oncology*Biology*Physics, vol.86, issue.3, pp.516-538, 2013. ,
DOI : 10.1016/j.ijrobp.2013.02.022
Analyse de textures dans les cancers pancréatiques avant et après radiochimiothérapie : nouveau paramètre prédictif? Soumission Abstract SFRO, 2017. ,